An induced pluripotent stem cell line (CIMRi001-A) from a Vici syndrome donor with a homozygous recessive c.1007A>G (p.Q336R) mutation in the EPG5 gene

Stem Cell Res. 2022 Aug:63:102833. doi: 10.1016/j.scr.2022.102833. Epub 2022 Jun 8.

Abstract

Vici syndrome is a rare, congenital disorder that affects multiple systems and is caused by mutations in the EPG5 gene that encodes for ectopic P-granules autophagy protein 5 (EPG5). The induced pluripotent stem cell (iPSC) line described here was generated from a dermal fibroblast cell line from an 8-year-old male donor with a homozygous recessive c.1007A>G (p.Q336R) mutation in the EPG5 gene. This iPSC model of Vici syndrome provides a unique and valuable resource for investigators to study the pathology of EPG5 mutations and the aetiology of the disease as well as develop therapeutic treatments for those with Vici syndrome.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Agenesis of Corpus Callosum
  • Autophagy-Related Proteins / genetics
  • Cataract
  • Child
  • Humans
  • Induced Pluripotent Stem Cells*
  • Male
  • Mutation / genetics
  • Vesicular Transport Proteins / genetics

Substances

  • Autophagy-Related Proteins
  • EPG5 protein, human
  • Vesicular Transport Proteins

Supplementary concepts

  • Absent corpus callosum cataract immunodeficiency